Themis Medicare logo

Themis Medicare financials: balance sheet, profit and loss, cash flow

NSE: THEMISMEDBSE: 530199Pharmaceuticals & BiotechnologySmall Cap

Themis Medicare Limited · Face value ₹1 · Listed May 1995 on BSE, Apr 2007 on NSE
Last close ₹97.52down ₹0.92 (0.93%)BSE ₹97.50

Share price at the NSE close on 29 Oct 2026. Previous close ₹98.44.

29 Oct: open ₹100.45, high ₹102.03, low ₹95.35

52-week range of traded prices to 29 Oct 2026
₹64.95Low, 30 Mar 2026₹140.60High, 7 Sep 2026
Market cap
₹898 Cr1,570th largest listed
P/E
22.47
P/E without one-offs
Lossover the last 12 months
P/B
2.25
Dividend yield
0.51%
ROE
10.0%
ROE without one-offs
−13.0%
ROCE
−10.5%
Debt to equity
0.25
Volume, NSE
51,63047.8% delivered

Themis Medicare's financial statements for the 10 years to Mar 2026, consolidated: the company and its subsidiaries together, with the twelve months to Jun 2026 after them.

10 years at a glance

₹ crore, years to March.Themis Medicare annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
24619Mar 1721211Mar 18184−1176Mar 192022588Mar 202313679Mar 213957379Mar 223545792Mar 233824496Mar 244063083Mar 253421.1100Mar 26
Peak revenue ₹406 Cr, year to Mar 2025; lowest ₹184 Cr, year to Mar 2019A loss in 1 of the 10 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin
24.2%−5.9%15.2%11.8%1.2%17.7%21.5%24.2%19.0%13.5%12.1%0.1%7.9%5.3%−5.9%12.3%15.5%18.5%16.1%11.4%7.4%0.3%Mar 17Mar 19Mar 21Mar 23Mar 25Mar 26

From Apr 2019 leases sit on the balance sheet: rent is charged as depreciation and interest instead, so operating profit and total assets step up with nothing about the business having changed. Borrowings here leave lease liabilities out. Lease payments were 1.3% of operating profit in the first full year.

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue342
  2. Materials and goods−129
  3. Employee costs−94
  4. Other expenses−119
  5. Operating profit0.4
  6. Depreciation−10
  7. Other income+9.4
  8. One-off items−0.9
  9. Finance costs−11
  10. Profit before tax−12
  11. Tax−0.8
  12. Joint ventures+14
  13. Net profit1.1

What the company owns

  • Plant, investments and other assets₹330 Cr
  • Receivables₹178 Cr
  • Inventory₹81 Cr
  • Cash and bank₹9 Cr

What pays for it: net worth and liabilities

  • Net worth₹399 Cr
  • Borrowings₹100 Cr
  • Owed to suppliers₹51 Cr
  • Other liabilities₹48 Cr

Profit and loss

Consolidated, ₹ crore, years to March. The last column is the twelve months to Jun 2026, the latest four quarters added.Themis Medicare quarterly results

₹ croreMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Filed 20 MayMar 2026Filed 28 MayJun 2026Twelve monthsFiled 13 Aug
Revenue from operations246212184202231395354382406342332
208187181166181299287330356342374
Materials and goods bought8372686379148118137132129135
Employee costs––464440526682969491
Other expenses––67586399102111128119148
Operating profit before depreciation372523649966752490−42
Operating margin15.2%11.8%1.2%17.7%21.5%24.2%19.0%13.5%12.1%0.1%−12.6%
Materials, % of revenue––37.2%31.3%34.1%37.5%33.4%35.8%32.5%37.8%40.7%
Employee costs, % of revenue––24.9%22.0%17.3%13.2%18.7%21.6%23.8%27.3%27.4%
Other expenses, % of revenue––36.7%29.0%27.1%25.1%28.9%29.1%31.6%34.7%44.5%
Depreciation and amortisation10788991012101010
Operating profit after depreciation2818−6274186573939−10−52
Other income333347125599
Finance costs11121213139109101111
Profit before one-off items and tax209−15183284593534−11−54
One-off items000000000−192
Profit before tax209−15183284593534−1238
10−22622161010115
Share of profit of joint ventures and associates1329911141961417
1911−11253673574430140
Other comprehensive income––00000−10−1−1
Total comprehensive income––−11253573564330039
Net margin7.9%5.3%−5.9%12.3%15.5%18.5%16.1%11.4%7.4%0.3%12.1%
Net margin without joint ventures and associates7.7%4.1%−7.1%7.9%11.4%15.6%12.2%6.5%5.9%−3.8%–
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the years to Mar 2017 and Mar 2018 they do not, so they are left blank.

Balance sheet

Consolidated, ₹ crore, at 31 March.

₹ croreMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Filed 20 MayMar 2026Filed 28 May
158183219287339378403399
158183219287339378403399
Share capital99999999
Reserves149174209278330368393389
Belonging to outside owners of subsidiaries00000000
76887979929683100
147155128110139155156166
912243135342933
Total assets314350371428514566588598
164169186214249273284293
150180185214265293304305
Net debt7383545273767091
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Consolidated, ₹ crore, years to March.

₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Filed 20 MayMar 2026Filed 28 May
57.034.416.114.534.7−3.3
56.952.532.223.445.5−3.8
7.9−42.6−40.3−20.9−5.1−2.0
Receivables24.9−23.0−44.5−32.90.8−1.0
Inventories−3.9−2.3−8.1−1.6−13.73.2
Payables1.11.18.27.24.1−0.6
Other working capital−14.2−18.44.16.43.6−3.6
Tax paid0.1−18.1−16.2−9.0−10.8−6.4
Interest paid0.00.00.00.00.08.9
Capital spending18.020.328.718.415.44.9
Free cash flow38.914.1−12.7−4.019.3−8.1
−15.7−15.2−24.0−15.9−12.2−2.5
−25.6−17.50.1−1.1−25.93.8
Dividends paid1.64.04.64.64.64.6
Shares bought back0.00.00.00.00.00.0
Shares issued0.00.40.10.00.00.2
Net change in cash15.71.6−7.7−2.6−3.4−2.0
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Consolidated, ₹ per share, years to March.Themis Medicare dividend history

₹ per shareMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Filed 20 MayMar 2026Filed 28 May
₹2.16₹1.22−₹1.17₹2.70₹3.89₹7.92₹6.18₹4.73₹3.24₹0.12
As stated that year₹21.56₹12.24−₹11.72₹26.97₹38.86₹79.22₹61.83₹4.73₹3.24₹0.12
₹2.10₹1.22−₹1.17₹2.70₹3.88₹7.91₹6.17₹4.72₹3.24₹0.12
–––₹0.18₹0.43₹0.50₹0.50₹0.50₹0.50₹0.50
––₹17.22₹19.92₹23.78₹31.25₹36.88₹41.03₹43.74₹43.28
Dividend payout–––6.5%11.1%6.3%8.1%10.6%15.4%402.6%
Shareholder yield––––0.6%0.4%0.4%0.2%0.3%0.7%
Market cap at the year end (₹ crore)5535152712202598621,0852,0121,353609
Every year is restated for later splits and bonuses, so they do not break the line. The figure the company stated that year is under each line it differs from.

Ratios

Consolidated, years to March.Themis Medicare PE ratio and valuation

RatioMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Filed 20 MayMar 2026Filed 28 May
Revenue growth5.6%−13.9%−13.2%9.7%14.4%71.1%−10.2%7.7%6.2%−15.6%
Operating profit growth−5.8%−33.2%−90.9%1,464.5%38.8%93.2%−29.5%−23.6%−4.8%−99.2%
Net profit growth0.9%−42.4%––44.1%104.1%−21.9%−23.5%−31.5%−96.2%
Earnings per share growth−5.0%−43.2%––44.1%103.9%−22.0%−23.5%−31.5%−96.3%
––−6.8%14.5%17.8%28.8%18.2%12.1%7.6%0.3%
–––21.3 pts3.3 pts11.0 pts−10.7 pts−6.0 pts−4.5 pts−7.4 pts
From the net margin–––21.1 pts3.8 pts3.4 pts−3.8 pts−5.3 pts−4.3 pts−7.3 pts
From asset turnover–––0.5 pts1.0 pts11.5 pts−6.0 pts−0.8 pts0.0 pts−0.1 pts
From borrowing–––−0.3 pts−1.5 pts−4.0 pts−0.9 pts0.0 pts−0.1 pts0.0 pts
Return on capital employed––−2.4%10.1%13.8%23.5%13.2%8.3%8.1%−2.0%
Cash conversion––––159.6%47.2%28.3%33.2%116.3%−285.5%
Interest cover2.51.5–2.13.29.86.04.23.9–
Debt to equity––0.480.480.360.270.270.250.210.25
Receivable days––14518612393149170159190
Inventory days––287315272150213188233229
Payable days––18717114379123126142143
Cash conversion cycle, days––244330251164239232250275
Working capital days––132176142123175180179222
Asset turnover––0.590.610.640.990.750.710.700.58
Assets per rupee of net worth––1.991.951.801.581.501.511.481.48
Sales per rupee of plant––1.511.751.782.782.202.272.362.06
Capital spending to depreciation––––2.112.142.741.501.550.47
Plant being built, % of plant in use––2.0%6.6%1.9%1.8%1.6%1.6%1.5%1.5%
Interest cover is left blank for the years to Mar 2019 and Mar 2026: operating profit after depreciation is a loss, and a loss covers no interest bill. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
0.2%
Cash from operations against operating profit
−830.4%
Measure10 years5 years3 years
Revenue growth, yearly rate3.9%8.2%−1.2%
Profit growth, yearly rate−24.6%−49.7%−72.8%
Return on equity, average–13.4%6.7%
Return on capital employed, average–10.2%4.8%
Operating margin, average13.6%13.8%8.6%
Net margin, average8.9%10.7%6.4%
Asset turnover, average–0.750.66
Cash conversion cycle, days, average–232253
Interest cover, average–6.04.0
Debt to equity, average–0.250.24

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations96.445.9−3.3
Cash from investing−69.9−30.7−2.5
Cash from financing−40.7−23.33.8
Capital spending87.738.74.9
Dividends paid22.413.84.6
Shares bought back0.00.00.0
Shares issued for cash0.70.20.2
Borrowings raised28.922.617.1
Borrowings repaid31.614.50.0

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––––664371
Altman Z-scorePublished threshold 1.81––2.272.443.016.536.058.536.553.59
Beneish M-scorePublished threshold −1.78––––−2.95−1.60−1.84−2.16−2.55−2.49
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––––−1.5613.4513.768.331.261.17
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––––––0.650.370.500.62
Receivables growth less revenue growthOur threshold 0 percentage points–––30.86−38.70−41.5054.4214.96−6.7016.18
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––9.31−17.25−84.5733.49−13.1522.92−1.92
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––−0.882.870.391.52−1.651.052.05
Assets under construction, years of additionsOur threshold 2 years of additions–––5.390.110.120.090.140.180.53
Effective tax ratePublished threshold 17.16 per cent3.481.17–11.6517.6726.6726.5128.6429.16–
Tax charged less tax paid, % of profitOur threshold 10 percentage points–––––5.13−0.922.78−2.69–
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
8 Oct 2026CARE Ratings LimitedTerm Loan-Long TermLong-term scaleCARE BB+Review, DowngradeStable39.54
8 Oct 2026CARE Ratings LimitedFund-based - LT-Cash CreditLong-term scaleCARE BB+Review, DowngradeStable37.85
8 Oct 2026CARE Ratings LimitedNon-fund-based - ST-BG/LCShort-term scaleCARE A4+Review, Downgrade48.50
8 Jun 2026Acuite Ratings & Research LimitedBank Loan RatingsACUITE BBB-Review, DowngradeStable45.35
8 Jun 2026Acuite Ratings & Research LimitedBank Loan RatingsACUITE A3Review, Downgrade83.75
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.